Evidence map›Paper›PMID 39334278›Full record

ReviewAntimicrobial resistance and infection control2024

Federated systems for automated infection surveillance: a perspective.

Stephanie M van Rooden, Suzanne D van der Werff, Maaike S M van Mourik, Frederikke Lomholt, Karina Lauenborg Møller, Sarah Valk, Carolina Dos Santos Ribeiro, Albert Wong, Saskia Haitjema, Michael Behnke and 1 more

Abstract readReview
In one paragraph

Review in Antimicrobial resistance and infection control, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. First steps in establishing surveillance of bloodstream infections from electronic health record derived data, EU/EEA countries, March 2023 to March 2025.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  3. Current state and potential of hospitals for automated healthcare-associated infection surveillance: data from 24 European countries, 2022 to 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stephanie M van RoodenDepartment of Epidemiology and Surveillance, Centre for Infectious Disease Epidemiology and Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. stephanie.van.rooden@rivm.nl.ORCID 0000-0002-3693-3991
Suzanne D van der WerffDivision of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-7162-3844
Maaike S M van MourikDepartment of Medical Microbiology and Infection Control, University Medical Centre Utrecht, Utrecht, The Netherlands.ORCID 0000-0003-2465-4132
Frederikke LomholtInfectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.ORCID 0009-0007-5284-2073
Karina Lauenborg MøllerInfectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-1430-5580
Sarah ValkDepartment of Epidemiology and Surveillance, Centre for Infectious Disease Epidemiology and Surveillance, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.ORCID 0000-0003-3964-2505
Carolina Dos Santos RibeiroCenter for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.ORCID 0000-0002-7148-0430
Albert WongDepartment of Statistics Data Science en Modelling, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Saskia HaitjemaCentral Diagnostic Laboratory, University Medical Centre Utrecht, Utrecht, The Netherlands.ORCID 0000-0001-5465-4868
Michael BehnkeInstitute of Hygiene and Environmental Medicine, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and, Berlin Institute of Health, Berlin, Germany.ORCID 0000-0002-3993-9651
Eugenia RinaldiCore Unit Digital Medicine and Interoperability, Berlin, Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0003-0343-6400

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Automation of surveillance of infectious diseases-where algorithms are applied to routine care data to replace manual decisions-likely reduces workload and improves quality of surveillance. However, various barriers limit large-scale implementation of automated surveillance (AS). Current implementation strategies for AS in surveillance networks include central implementation (i.e. collecting all data centrally, and central algorithm application for case ascertainment) or local implementation (i.e. local algorithm application and sharing surveillance results with the network coordinating center). In this perspective, we explore whether current challenges can be solved by federated AS. In federated AS, scripts for analyses are developed centrally and applied locally. We focus on the potential of federated AS in the context of healthcare associated infections (AS-HAI) and of severe acute respiratory illness (AS-SARI). AS-HAI and AS-SARI have common and specific requirements, but both would benefit from decreased local surveillance burden, alignment of AS and increased central and local oversight, and improved access to data while preserving privacy. Federated AS combines some benefits of a centrally implemented system, such as standardization and alignment of an easily scalable methodology, with some of the benefits of a locally implemented system including (near) real-time access to data and flexibility in algorithms, meeting different information needs and improving sustainability, and allowance of a broader range of clinically relevant case-definitions. From a global perspective, it can promote the development of automated surveillance where it is not currently possible and foster international collaboration.The necessary transformation of source data likely will place a significant burden on healthcare facilities. However, this may be outweighed by the potential benefits: improved comparability of surveillance results, flexibility and reuse of data for multiple purposes. Governance and stakeholder agreement to address accuracy, accountability, transparency, digital literacy, and data protection, warrants clear attention to create acceptance of the methodology. In conclusion, federated automated surveillance seems a potential solution for current barriers of large-scale implementation of AS-HAI and AS-SARI. Prerequisites for successful implementation include validation of results and evaluation requirements of network participants to govern understanding and acceptance of the methodology.

Indexed as

AlgorithmsAutomationCross InfectionEpidemiological MonitoringHumansRespiratory Tract InfectionsAutomated surveillanceEthical Legal Societal ImplicationsFederated systemsGovernanceHealthcare associated infectionsImplementationInteroperabilitySevere acute respiratory infectionsStandards

Identifiers

PMID39334278
PMCPMC11438042

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.